Investment
Features
FeesSafety
Academy
More
Pluang+

Century Communities launches Martins Glen with 5 new home plans from the low $400s near Nashville

Market News
28 Sep 2026
PRNewsWire
View Source
Bullish
Century Communities launches Martins Glen with 5 new home plans from the low $400s near Nashville

Century Communities is opening Martins Glen, a new home community in Antioch, Tennessee, on October 3, 2026. The community offers five two-story single-family home plans ranging from 1,942 to 2,800 square feet, priced from the low $400,000s. Located 18 miles from downtown Nashville, Martins Glen features amenities like a playground and walking trail, with convenient access to local shopping, highways, and Percy Priest Lake. The launch includes a tour of the newly decorated Meadowlark model home, highlighting flexible living spaces and smart home features, appealing to buyers seeking modern, adaptable homes near the city.

Century Communities' new home community opening near Nashville is the story subject, with Pluang's real estate sector showing a breadth of 26 stocks, where 4 rose and 22 fell as of Sep 28, 2026 22:02 WIB. Notable movers include Orion Office REIT Inc (ONL) at USD 2.49, down 0.80%, American Tower Corp (AMT) at USD 167.75, down 0.76%, and AGNC Investment Corp (AGNC) at USD 9.55, down 0.73%.

More News

Vertex Pharmaceuticals rises on strong cystic fibrosis sales and promising kidney drug trials, UBS hikes price target.

Vertex Pharmaceuticals rises on strong cystic fibrosis sales and promising kidney drug trials, UBS hikes price target.

Vertex Pharmaceuticals reported a 12% revenue increase to $3.33 billion in Q2, driven by its dominant cystic fibrosis treatments. UBS raised its price target from $585 to $615, reflecting confidence in Vertex's strong financials and growth potential....

Analyst Insights
Bullish
2 hours ago
Accenture's stock jumps 37.6% on booming AI demand and strong financials ahead of Q4 earnings.

Accenture's stock jumps 37.6% on booming AI demand and strong financials ahead of Q4 earnings.

Accenture's stock surged 37.6% recently, driven by rising demand for AI services and new AI-focused offerings. The company outpaced industry growth and secured 100 new clients for advanced AI projects in one quarter. An analyst raised the price targe...

Analyst Insights
Bullish
3 hours ago
SpaceX nears Starship's first orbital launch and Starlink V3 deployment, boosting investor optimism.

SpaceX nears Starship's first orbital launch and Starlink V3 deployment, boosting investor optimism.

SpaceX, trading near $148 per share with a market cap of about $1.95 trillion, is preparing for Starship's first orbital mission and the deployment of its first operational Starlink V3 satellites. This milestone is key for expanding Starlink's global...

Market News
Bullish
3 hours ago
10x Genomics gets Buy rating despite insider selling and valuation concerns.

10x Genomics gets Buy rating despite insider selling and valuation concerns.

Argus Research initiated coverage on 10x Genomics with a Buy rating and a $110 price target, suggesting a 28% upside from its current price of around $85. The stock shows strong momentum, trading well above its 50-day and 200-day moving averages. How...

Analyst Insights
Neutral
4 hours ago
Morgan Stanley upgrades Cullen/Frost Bankers with strong institutional buying and a $201 price target.

Morgan Stanley upgrades Cullen/Frost Bankers with strong institutional buying and a $201 price target.

Morgan Stanley reaffirmed an "Overweight" rating on Cullen/Frost Bankers, Inc., raising its price target to $201, signaling confidence in the bank's prospects. Major institutional investors like State Street Corp and BlackRock have increased or initi...

Analyst Insights
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App